Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

Role of Liver Biopsy in the Evaluation of Hepatitis C Virus Infection in HIV Coinfection

Richard K. Sterling
Clinical Infectious Diseases
Vol. 40, Supplement 5. Hepatitis C Virus Infection and Substance Abuse: Medical Management and Developing Models of Integrated Care (Apr. 15, 2005), pp. S270-S275
Published by: Oxford University Press
Stable URL: http://www.jstor.org/stable/4484131
Page Count: 6
  • Download ($42.00)
  • Subscribe ($19.50)
  • Cite this Item
Role of Liver Biopsy in the Evaluation of Hepatitis C Virus Infection in HIV Coinfection
Preview not available

Abstract

Hepatitis C virus (HCV) coinfection is common in patients infected with human immunodeficiency virus (HIV), because the viruses share common routes of transmission. With the marked increase in life expectancy of HIV-infected patients associated with the use of highly active antiretroviral therapy, HCV infection has become a significant cause of morbidity and mortality in coinfected patients. As a result, there has been increasing attention to adequate assessment of HCV infection during the last several years. Unlike liver enzymes and HCV RNA levels, which can fluctuate widely and do not correlate with the severity of disease, liver biopsy has become the cornerstone in the evaluation of chronic HCV infection. However, there remain important questions and controversies related to adequately determining the histological severity of liver disease and the role of liver biopsy in HIV-HCV-coinfected patients.

Page Thumbnails

  • Thumbnail: Page 
S270
    S270
  • Thumbnail: Page 
S271
    S271
  • Thumbnail: Page 
S272
    S272
  • Thumbnail: Page 
S273
    S273
  • Thumbnail: Page 
S274
    S274
  • Thumbnail: Page 
S275
    S275